Generally, an increased vimentin expression and decreased E‐cadherin and CK expression signify EMT progression and enhanced migratory behavior in cancer cells.[79] The vimentin expression remained similar across all treatments (Figure S14a, Supporting Information) and is highly expressed in PC3 cells due to their highly metastatic phenotype.[37] Vimentin expression was highest for the 0 h treatment group (81.5%), decreasing most notably for the 0.5 and 1 h regimens (Figure S14d, Supporting Information). This evidence concerns the gene CDH1 and cancer.